dual pathway weight loss

Aug 26

How AI and Dual-Pathway Drugs Are Shaping Next-Gen Weight Loss

By Damian Williams Medical Weight Loss

Takeaways Dual‑pathway therapies deliver stronger, longer-lasting fat loss while preserving lean mass. AI‑guided dosing promises smarter personalization, improving adherence and real‑world outcomes. The oral and injectable co‑agonist amycretin marks a breakthrough in obesity…

Testosterone Replacement Therapy

The Rise of Bioengineered Ovaries: Toward a Physiologic Alternative to HRT

Takeaways Bioengineered ovary scaffolds may one day restore hormone function more naturally than conventional HRT. These implants aim to mimic feedback loops and hormone cycles rather than deliver static doses. Clinical use remains…

Medical Weight Loss

Muscle-Preserving Combos: The Promise of Bimagrumab + GLP‑1 in Advanced Weight Management

Takeaways Bimagrumab plus GLP-1 therapy may preserve muscle while promoting near-total fat loss. Protecting lean mass improves long-term strength, metabolism, and quality of life. Functional outcomes, not just body composition, will shape future…

Medical Weight Loss

Single-Shot Incretin Gene Therapy for Obesity: RJVA-002 and the Future of Endogenous GLP-1/GIP Modulation

Takeaways RJVA-002 uses gene therapy to deliver GLP-1 and GIP directly from pancreatic beta cells in a nutrient-responsive way. Preclinical studies in obese mice show up to 30% body weight loss and improved…

CHECK OUT OUR BLOG HERE